These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 8525523

  • 1. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
    Rollins SA, Matis LA, Springhorn JP, Setter E, Wolff DW.
    Transplantation; 1995 Dec 15; 60(11):1284-92. PubMed ID: 8525523
    [Abstract] [Full Text] [Related]

  • 2. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ, Rollins SA, Dalmasso AP, Elliott EA, Matis LA, Squinto SP, Bolman RM.
    Transplantation; 1995 Dec 15; 60(11):1194-202. PubMed ID: 8525509
    [Abstract] [Full Text] [Related]

  • 3. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP, Rollins SA, Burton WV, Sims PJ, Bothwell AL, Squinto SP, Zavoico GB.
    Transplantation; 1994 May 27; 57(10):1494-501. PubMed ID: 7515200
    [Abstract] [Full Text] [Related]

  • 4. CD59 efficiently protects human NT2-N neurons against complement-mediated damage.
    Pedersen ED, Aass HC, Rootwelt T, Fung M, Lambris JD, Mollnes TE.
    Scand J Immunol; 2007 May 27; 66(2-3):345-51. PubMed ID: 17635812
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil adhesion to xenogeneic endothelium via iC3b.
    Vercellotti GM, Platt JL, Bach FH, Dalmasso AP.
    J Immunol; 1991 Jan 15; 146(2):730-4. PubMed ID: 1987283
    [Abstract] [Full Text] [Related]

  • 6. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
    Galbusera M, Buelli S, Gastoldi S, Macconi D, Angioletti S, Testa C, Remuzzi G, Morigi M.
    Xenotransplantation; 2005 Mar 15; 12(2):110-20. PubMed ID: 15693841
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B, Matthijsen RA, Wolfs TG, Van Bijnen AA, Heeringa P, Buurman WA.
    Transplantation; 2003 Feb 15; 75(3):375-82. PubMed ID: 12589162
    [Abstract] [Full Text] [Related]

  • 8. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 15; 131(5):2570-5. PubMed ID: 6355297
    [Abstract] [Full Text] [Related]

  • 9. The release of C5a in complement-activated serum does not require C6.
    Biesecker G, Wagner JL, Hugli TE.
    J Immunol; 1989 Aug 15; 143(4):1228-32. PubMed ID: 2545783
    [Abstract] [Full Text] [Related]

  • 10. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
    Ollert MW, Kadlec JV, David K, Petrella EC, Bredehorst R, Vogel CW.
    J Immunol; 1994 Sep 01; 153(5):2213-21. PubMed ID: 8051421
    [Abstract] [Full Text] [Related]

  • 11. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy.
    Cybulsky AV, Quigg RJ, Salant DJ.
    J Immunol; 1986 Sep 01; 137(5):1511-6. PubMed ID: 3745914
    [Abstract] [Full Text] [Related]

  • 12. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 13. Xenotransplantation: state of the art.
    Lavitrano M, Frati L.
    Forum (Genova); 1999 Feb 01; 9(3 Suppl 3):74-83. PubMed ID: 10607850
    [Abstract] [Full Text] [Related]

  • 14. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL, Sodetz JM.
    Mol Immunol; 2007 Feb 01; 44(5):960-5. PubMed ID: 16624411
    [Abstract] [Full Text] [Related]

  • 15. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH, Hänsch G, Gresham HD, Shin ML.
    J Immunol; 1983 Aug 01; 131(2):892-8. PubMed ID: 6863934
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of complement component C5 protects porcine chondrocytes from xenogeneic rejection.
    Sommaggio R, Pérez-Cruz M, Brokaw JL, Máñez R, Costa C.
    Osteoarthritis Cartilage; 2013 Dec 01; 21(12):1958-67. PubMed ID: 24041966
    [Abstract] [Full Text] [Related]

  • 17. Terminal complement components play a role in the expression of C5a.
    Gresham HD, Renfer L, Hammer CH, Frank MM.
    J Immunol; 1987 Feb 01; 138(3):838-41. PubMed ID: 3805718
    [Abstract] [Full Text] [Related]

  • 18. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL, Kolb WP, Sodetz JM.
    J Immunol; 1987 Sep 15; 139(6):1960-4. PubMed ID: 3624872
    [Abstract] [Full Text] [Related]

  • 19. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H, Tsuboi M, Nagaki K.
    Immunology; 1986 Jul 15; 58(3):459-65. PubMed ID: 3733147
    [Abstract] [Full Text] [Related]

  • 20. A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements.
    Lin X, Qi JZ, Chen MH, Qiu BT, Huang ZH, Qiu PX, Chen JS, Yan GM.
    Biochem Pharmacol; 2013 Mar 15; 85(6):772-9. PubMed ID: 23178656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.